Sitemap

Vol.4 - No.4 (December 2013)

REVIEW ARTICLE

Pathophysiology and early diagnosis of diabetic macroangiopathy

N. Katakami 205

REPORT OF THE COMMITTEE

Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012)

E. Kawasaki, T. Maruyama, A. Imagawa, T. Awata, H. Ikegami, Y. Uchigata, H. Osawa, Y. Kawabata, T. Kobayashi, A. Shimada, I. Shimizu, K. Takahashi, M. Nagata, H. Makino, T. Hanafusa 221

ORIGINAL ARTICLES

Combined treatment with low-dose pioglitazone and beraprost sodium improves glucose intolerance without causing body weight gain

H. Kumagai, N. Kubota, T. Kubota, T. Takahashi, M. Inoue, T. Kawai, K. Iwayama, M. Moroi, K. Sugi, T. Kadowaki 226

Evaluation of stepwise insulin treatment as an add-on to current oral antidiabetic drugs therapy in Japanese patients with type 2 diabetes: STEADY study

T. Nakagami, M. Honda, N. Shibata, O. Tomonaga, M. Tanaka, H. Kanno, J. Miura, M. Osawa, H. Takaike, Y. Iwamoto, Y. Uchigata 233

The area of abdominal subcutaneous adipose tissue is independently correlated with C-peptide increment during glucagon load in Japanese patients with type 2 diabetes

K. Matsumoto, A. Kanazawa, F. Ikeda, C. Ohmura, T. Shimizu, Y. Tamura, Y. Fujitani, R. Kawamori, H. Watada 243

Determinants of the HbA1c-lowering effect of sitagliptin when added to ongoing insulin therapy in Japanese patients with type 2 diabetes

Y. Bando, K. Ishikura, H. Kanehara, K. Aoki, A. Hisada, D. Toya, N. Tanaka 251

CASE REPORT

A diabetic patient with hemoglobin variant Hb Mito diagnosed from a change in HbA1c measurement method

M. Higa, A. Yoshifuji, A. Doi, E. Yoshida, K. Yamashita, T. Ichijo, H. Ouchi, A. Miyazaki, T. Hirose 257

SHORT COMMUNICATION

A report on diabetes seminars for medical staff: findings from a questionnaire survey

M. Kishimoto, M. Noda 261

ERRATUM

Erratum to: Evaluation of a new device for measurement of hemoglobin A1c for Japanese subjects

S. Shimoda, T. Maeda, N. Furukawa, K. Ichinose, K. Taketa, M. Igata, T. Senokuchi, T. Matsumura, E. Araki 266

Erratum to: Glycated albumin as a useful clinical biomarker for glycemic variability in type 1 diabetes assessed by continuous glucose monitoring

C. Tsutsumi, A. Imagawa, M. Onishi, H. Sano, S. Nakagawa, Y. Murase-Mishiba, J. Terasaki, T. Hanafusa 267

Update: December 28, 2018